
Quarterly report 2022-Q2
added 08-09-2022
Radius Health Market Cap 2011-2025 | RDUS
As of December 30, 2025 Radius Health has a market cap of $ 1.42 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Radius Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 378 M | 869 M | 823 M | 820 M | 1.71 B | 1.82 B | 1.27 B | 853 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.82 B | 378 M | 1.07 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Drug manufacturers industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
101 M | - | - | $ 142 M | ||
|
Aerie Pharmaceuticals
AERI
|
325 M | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
142 M | $ 1.21 | 1.68 % | $ 130 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
22.2 M | - | 7.5 % | $ 6.35 M | ||
|
Cronos Group
CRON
|
3.63 B | $ 2.67 | 0.19 % | $ 1.39 B | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
18 M | - | 0.86 % | $ 117 M | ||
|
Catalent
CTLT
|
10.9 B | - | - | $ 11.5 B | ||
|
Agile Therapeutics
AGRX
|
1.29 M | - | 10.11 % | $ 58.2 M | ||
|
DURECT Corporation
DRRX
|
31.8 M | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
340 M | - | -39.89 % | $ 27.7 M | ||
|
Aurora Cannabis
ACB
|
915 M | $ 4.35 | -3.12 % | $ 86.3 M | ||
|
Endo International plc
ENDP
|
68.2 M | - | - | $ 28.9 M | ||
|
Zomedica Corp.
ZOM
|
137 M | - | -0.21 % | $ 98 M | ||
|
Evoke Pharma
EVOK
|
2.24 M | - | - | $ 36.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
966 M | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
89 M | - | 2.45 % | $ 38.1 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
18.8 M | - | - | $ 55.5 M | ||
|
Emergent BioSolutions
EBS
|
139 M | $ 12.29 | -1.09 % | $ 629 M | ||
|
Athenex
ATNX
|
11.4 M | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
717 M | $ 21.57 | -0.12 % | $ 2.05 B | ||
|
Evolus
EOLS
|
887 M | $ 6.66 | -3.55 % | $ 413 M | ||
|
Harrow Health
HROW
|
347 M | $ 50.7 | 1.22 % | $ 1.65 B | ||
|
China Pharma Holdings
CPHI
|
4.54 M | $ 1.27 | -1.32 % | $ 22.2 M | ||
|
OrganiGram Holdings
OGI
|
382 M | $ 1.7 | -5.31 % | $ 402 M | ||
|
Neoleukin Therapeutics
NLTX
|
1.72 M | - | - | $ 193 M | ||
|
Organogenesis Holdings
ORGO
|
415 M | $ 5.19 | -1.71 % | $ 683 M | ||
|
Bausch Health Companies
BHC
|
3.38 B | $ 7.16 | -0.56 % | $ 2.61 B | ||
|
Lannett Company
LCI
|
39.4 M | - | 1.15 % | $ 7.11 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
3.66 M | $ 3.66 | 0.83 % | $ 4.54 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
88.6 M | $ 4.01 | -2.55 % | $ 56.4 M | ||
|
Rockwell Medical
RMTI
|
35.5 M | $ 0.8 | -7.01 % | $ 18.7 M | ||
|
Pacira BioSciences
PCRX
|
1.18 B | $ 26.17 | -1.3 % | $ 1.21 B | ||
|
Sundial Growers
SNDL
|
889 K | $ 1.71 | -1.16 % | $ 3.37 M | ||
|
PetIQ
PETQ
|
396 M | - | 1.64 % | $ 400 M | ||
|
Jupiter Wellness
JUPW
|
82.8 M | - | - | $ 33.6 M | ||
|
Veru
VERU
|
108 M | $ 2.22 | -7.71 % | $ 299 M | ||
|
Perrigo Company plc
PRGO
|
3.96 B | $ 13.94 | 0.87 % | $ 1.92 B | ||
|
ProPhase Labs
PRPH
|
131 M | $ 0.45 | -14.17 % | $ 7.13 M | ||
|
cbdMD
YCBD
|
1.68 M | $ 1.43 | -15.88 % | $ 6.17 M | ||
|
Recro Pharma
REPH
|
133 M | - | -4.76 % | $ 65.3 M | ||
|
Relmada Therapeutics
RLMD
|
162 M | $ 4.43 | -1.77 % | $ 133 M | ||
|
OptiNose
OPTN
|
192 M | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
66.1 M | $ 9.56 | -3.82 % | $ 679 M | ||
|
PLx Pharma
PLXP
|
118 M | - | -27.8 % | $ 2.56 M | ||
|
Solid Biosciences
SLDB
|
226 M | $ 5.63 | -3.68 % | $ 230 M | ||
|
SCYNEXIS
SCYX
|
70.3 M | $ 0.63 | 6.75 % | $ 30.1 M | ||
|
Tricida
TCDA
|
359 M | - | - | $ 3.25 M | ||
|
Tilray
TLRY
|
1.19 B | $ 9.32 | -2.87 % | $ 5.76 B | ||
|
TherapeuticsMD
TXMD
|
23.9 M | $ 1.68 | -3.43 % | $ 17.5 M |